Show all News

We are working to develop our technology and commercialise MSC-based pharmaceuticals – find out more about our day-to-day work.

We’ve begun the process of accelerating thanks to MIT Enterprise Forum Poland

We are one of 18 innovative companies taking part in the 5th edition of MIT Enterprise Forum Poland accelerator program. There are three months of hard work and immense, new challenges ahead. If we are lucky enough to be among those who are selected to move on, our next stop is Boston Massachusetts,, USA, where we will take part in a special Bootcamp. Oh! Did we forget to mention that there’s also 100k PLN up for grabs in the CVC Young Innovator Awards contest? During the accelerator program we’ll be taught some plain English: learning how to present an innovative tech solution in a way that customers, partners and investors around the world are able to understand. There will also be a chance to take our innovative business idea out on a trial run, testing it using the expert opinions and technical resources provided by program partners.

Wrote about us

Bioceltix has the power to change the world

Many biotech startups are spending money from investors and grants by the billions, in an effort to find new ways of treating humans, but some of them have chosen to focus their attention on animals. Bioceltix does business on this developing market of veterinary products. Developing innovative ...


Five life science start-ups that can change the world

We have found ourselves in the ranking of the 5 most promising Polish start-ups prepared by! “From those looking for a drug to cure cancer, through manufacturers of at-home lab devices, up to scientists who want to set stem cells to save the lives of animals. Poland seems to be ...


Łukasz Bzdzion on Radio Wrocław

Łukasz Bzdzion visited Filip Marczyński on Radio Wrocław. The CEO of Bioceltix talked about biological drugs for animals that are currently developed with the use of mesenchymal stem cells, and also about the entire team’s plans for the nearest future. You can listen to the full interview here.


Veterinary biological drugs – Bioceltix summarizes the year 2018

For Bioceltix, last year was filled with new, exciting challenges. From rankings and accelerator programs to contests and even a newly-opened #lab – it’s been a busy time. The ultimate goal remains unchanged – launching innovative biopharmaceuticals for #animals… and we’re ...


Bioceltix is ​​working on drugs based on stem cells for animals [interview]

MamStartup: Bioceltix is a biotech startup that does business in the veterinary industry – the company focuses on developing stem-cell-based biopharmaceuticals.  These biopharmaceuticals are a safer as well as more effective alternative to synthetic drugs, which treat only symptoms, not ...